The Use of Control Group in the Sports Science Research: The Ethical Challenge

Detalhes bibliográficos
Autor(a) principal: Louro, Gonçalo
Data de Publicação: 2023
Outros Autores: Ferraz, Ricardo, Forte, Pedro, Teixeira, José E., Branquinho, Luís, Esteves, Dulce
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.6063/motricidade.27838
Resumo: Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.
id RCAP_591f5ffa2c2b2bf013496185ab5045ce
oai_identifier_str oai:ojs.revistas.rcaap.pt:article/27838
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The Use of Control Group in the Sports Science Research: The Ethical ChallengeResearch NoteMedical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.Os especialistas em ética médica questionaram o uso de estudos controlados sem tratamento (procedimento placebo e simulado) de novas terapias quando terapias padrão seguras e eficazes estão disponíveis para uso como controlo ativo ou de “equivalência”. Os atuais princípios éticos de conduta para pesquisa biomédica proíbem especificamente projetos que retenham ou neguem o “melhor diagnóstico comprovado e tratamento terapêutico” a qualquer participante de um ensaio clínico, incluindo aqueles indivíduos que consentem com a randomização em um grupo de controle. Estudos de terapias psicofisiológicas são frequentemente criticados por não terem um grupo controle de tratamento placebo ou simulado. Na pesquisa em ciências do desporto, particularmente no caso do exercício clínico, o uso de grupos de controle também levanta questões éticas. Este artigo aborda brevemente o problema e discute os padrões éticos que regem a pesquisa em humanos derivados do Código de Nuremberg e da Declaração de Helsínquia.Edições Sílabas Didáticas2023-03-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.6063/motricidade.27838eng2182-29721646-107XLouro, GonçaloFerraz, RicardoForte, PedroTeixeira, José E.Branquinho, LuísEsteves, Dulceinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-31T13:45:36Zoai:ojs.revistas.rcaap.pt:article/27838Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:49:58.566564Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The Use of Control Group in the Sports Science Research: The Ethical Challenge
title The Use of Control Group in the Sports Science Research: The Ethical Challenge
spellingShingle The Use of Control Group in the Sports Science Research: The Ethical Challenge
Louro, Gonçalo
Research Note
title_short The Use of Control Group in the Sports Science Research: The Ethical Challenge
title_full The Use of Control Group in the Sports Science Research: The Ethical Challenge
title_fullStr The Use of Control Group in the Sports Science Research: The Ethical Challenge
title_full_unstemmed The Use of Control Group in the Sports Science Research: The Ethical Challenge
title_sort The Use of Control Group in the Sports Science Research: The Ethical Challenge
author Louro, Gonçalo
author_facet Louro, Gonçalo
Ferraz, Ricardo
Forte, Pedro
Teixeira, José E.
Branquinho, Luís
Esteves, Dulce
author_role author
author2 Ferraz, Ricardo
Forte, Pedro
Teixeira, José E.
Branquinho, Luís
Esteves, Dulce
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Louro, Gonçalo
Ferraz, Ricardo
Forte, Pedro
Teixeira, José E.
Branquinho, Luís
Esteves, Dulce
dc.subject.por.fl_str_mv Research Note
topic Research Note
description Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.6063/motricidade.27838
url https://doi.org/10.6063/motricidade.27838
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2182-2972
1646-107X
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Edições Sílabas Didáticas
publisher.none.fl_str_mv Edições Sílabas Didáticas
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131580230270976

Registros relacionados